In models of ALS, fluvoxamine has also been shown to stabilize proteins like nucleoporin Pom121, which facilitates the translocation of TFEB, enhancing autophagy and lysosomal function, which is crucial in the pathology of most of neurodegenerative diseases [129]. The gene discussed is TFEB; the disease is neurodegenerative disease.